Emilie Thivat

Summary

Affiliation: Centre Jean Perrin
Country: France

Publications

  1. ncbi Neutrophils are immune cells preferentially targeted by retinoic acid in elderly subjects
    Régine Minet-Quinard
    Clermont University, Universite d Auvergne, EA4233, LB2MN, CRNH A, BP10448, F 63000 Clermont Ferrand, France
    Immun Ageing 7:10. 2010
  2. ncbi Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse
    Emilie Thivat
    Division of Clinical Research, Centre Jean Perrin, Clermont Ferrand, F 63011 France
    BMC Cancer 10:648. 2010
  3. ncbi Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study
    Xavier Durando
    Centre Jean Perrin, Unite de recherche clinique, UMR 990, université Clermont 1, UFR Medecine, CIC 501, Clermont Ferrand, France
    Oncology 78:205-9. 2010
  4. ncbi A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)
    Philippe Chollet
    Centre Jean Perrin, Clermont Ferrand, France
    Cancer J 14:128-32. 2008
  5. ncbi Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial
    Xavier Durando
    Centre Jean Perrin, Unite de recherche clinique, université Clermont 1, UFR Medecine, INSERM UMR 484, and Centre d Investigation Clinique, Clermont Ferrand, France
    Nutr Cancer 60:23-30. 2008

Collaborators

  • Marie Ange Mouret-Reynier
  • Xavier Durando
  • Philippe Chollet
  • Régine Minet-Quinard
  • Marie Paule Vasson
  • Catherine Abrial
  • Marie Chantal Farges
  • M Paule Vasson
  • Brigitte Gillet
  • Brigitte Winklhofer-Roob
  • Emmanuel Buc
  • M Chantal Farges
  • Denis Pezet
  • Caroline Petorin-Lesens
  • Edmond Rock
  • Gilles Mayot
  • Josep Ribalta
  • Cécile Deleine
  • Julius Brtko
  • Olivier Tacca
  • Marie-Chantal Farges
  • Fabrice Kwiatkowski
  • Frédérique Penault-Llorc
  • Jacques Dauplat
  • Marie-Paule Vasson
  • Chantal Barthomeuf
  • Eric Cellarier
  • Marianne Leheurteur
  • Michel d'Incan
  • Aicha Demidem

Detail Information

Publications5

  1. ncbi Neutrophils are immune cells preferentially targeted by retinoic acid in elderly subjects
    Régine Minet-Quinard
    Clermont University, Universite d Auvergne, EA4233, LB2MN, CRNH A, BP10448, F 63000 Clermont Ferrand, France
    Immun Ageing 7:10. 2010
    ..5 mg/kg/day during 28 days), whole blood cells were phenotyped, and functions of peripheral blood mononuclear cells (PBMC) and polymorphonuclear cells (PMN) were investigated by flow cytometry and ELISA tests...
  2. ncbi Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse
    Emilie Thivat
    Division of Clinical Research, Centre Jean Perrin, Clermont Ferrand, F 63011 France
    BMC Cancer 10:648. 2010
    ..Our study was aimed to evaluate the prognostic value of weight change during anthracycline-based chemotherapy on non metastatic breast cancer (European population) with a long term follow-up...
  3. ncbi Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study
    Xavier Durando
    Centre Jean Perrin, Unite de recherche clinique, UMR 990, université Clermont 1, UFR Medecine, CIC 501, Clermont Ferrand, France
    Oncology 78:205-9. 2010
    ....
  4. ncbi A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)
    Philippe Chollet
    Centre Jean Perrin, Clermont Ferrand, France
    Cancer J 14:128-32. 2008
    ..Among the most useful are node involvement, tumor size, and pathologic grade. These factors retained their prognostic value when assessed after neoadjuvant chemotherapy...
  5. ncbi Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial
    Xavier Durando
    Centre Jean Perrin, Unite de recherche clinique, université Clermont 1, UFR Medecine, INSERM UMR 484, and Centre d Investigation Clinique, Clermont Ferrand, France
    Nutr Cancer 60:23-30. 2008
    ..Based on these results, a Phase II clinical trial has been initiated to test the activity of the association of a 1-day MET-free diet with cystemustine treatment...